Life Spine announces initiation of PROLIFT Expandable Interbody clinical study

131

Life Spine has announced the initiation of the PROLIFT Expandable clinical study with Ahmed Khan, Central Connecticut Neurosurgery and Spine, Connecticut, USA.

Mariusz Knap, vice president of Marketing and Business Development notes, “Clinical studies are the foundation for advancing innovative spine care and Life Spine is committed to a robust investment into clinical studies to evaluate the safety and efficacy of our products, as well as demonstrating possible medical economic savings and advantages associated with new technologies such as PROLIFT.”

PROLIFT Expandable Interbody System allows for in-situ disc height restoration for micro-invasive PLIF, traditional TLIF and oblique TLIF approaches. PROLIFT also incorporates the proprietary surface technology OSSEO-LOC and multiple lordotic options which provide the surgeon the ability to restore normal spinal pelvic parameters.

Ahmed Khan, principal investigator for the clinical study, notes, “Expandable interbodies have been effective to restore or maintain lumbar lordosis and disc height with reduced iatrogenic impact. However, outcome studies need to be performed to allay clinical ethicists and evaluate long-term patient outcomes.”

(Visited 31 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here